SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Trading Statement

1 Dec 2011 07:00

RNS Number : 1205T
Breedon Aggregates Ld
01 December 2011
 



 

1 December 2011

 

BREEDON AGGREGATES LIMITED

("Breedon" or the "Group")

 

Trading Update

 

Breedon Aggregates Limited issues the following statement in advance of its preliminary results announcement due on 6 March 2012.

 

Trading Performance

 

Anticipated trading results for the year to 31 December 2011 remain comfortably in line with market expectations, assuming normal weather conditions in December. Sales volumes have held up well, with growth across all product groups in both Scotland and England, including a positive contribution from C&G Concrete. Sales revenue for the ten months ended 31 October 2011 increased by 20% to £153 million, including £4.9 million from the former C&G business compared to pro forma 2010 revenues of £127.7 million.

 

Operational progress

 

Good progress has been made in addressing all the main operational issues identified at the start of the year. The English contracting business has been returned to profit, numerous asset disposals have been completed and the Group's mineral reserves have been substantially increased. Most notably, all key raw material cost increases have been recovered during the year. C&G has proved to be an excellent acquisition and we are well on the way to delivering the anticipated synergies from that business.

 

Outlook

 

The outlook for 2012 is uncertain as forecast growth in the economy slows. The Construction Products Association anticipates a 3.6 per cent. fall in construction output and the full impact of public sector spending cuts has yet to be felt, particularly in Scotland. However, the increases in English housing and infrastructure spending announced recently by the Government are very welcome and should have a positive impact on demand for our products in the medium term.

 

The Directors continue to believe that there is significant scope to further develop the Group. The current market conditions will inevitably create further opportunities to purchase assets at realistic prices and several acquisition opportunities are currently under review. The Board has every expectation of making further progress in the year ahead.

- ends -

 

 

 

 

More about Breedon Aggregates

 

Breedon Aggregates Limited is the largest independent aggregates group in the UK after the five global majors. It operates 26 quarries, 18 asphalt plants and 40 ready-mixed concrete plants in England and Scotland and employs approximately 800 people.

 

The Group has strong asset backing, with nearly 200 million tonnes of mineral reserves and resources in the UK.

 

Breedon Aggregates' strategy is to grow through consolidation of the UK heavyside building materials sector.

 

 

For further information:

 

Breedon Aggregates Limited

Peter Tom, Chairman

01481 232553 / 07850 066000

Ian Peters, Group Finance Director

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc

Nicholas Wells / Max Hartley

020 7397 8900

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVBLFXFFFFFBV
Date   Source Headline
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition
28th May 202110:02 amRNSTotal Voting Rights
7th May 20219:28 amRNSStandard form for notification of major holdings
23rd Apr 20211:46 pmRNSDirectors’ and PDMRs’ Dealings
23rd Apr 20211:37 pmRNSPDMR Dealings
20th Apr 20212:36 pmRNSResult of AGM
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 202111:04 amRNSGrant of SAYE Options and PDMR Dealings
1st Apr 20217:00 amRNSBoard Update
23rd Mar 202111:13 amRNSDirector Dealings
23rd Mar 202111:09 amRNS2020 Annual Report and Notice of AGM
10th Mar 20217:01 amRNSDirectorate Change
10th Mar 20217:00 amRNSAnnual Results 2020
26th Feb 20219:15 amRNSTotal Voting Rights
22nd Jan 20211:55 pmRNSDirector/PDMR Shareholding
22nd Jan 20218:46 amRNSAdditional Block Listing of Ordinary Shares
13th Jan 20217:00 amRNSAppointment of Corporate Broker
7th Jan 20212:45 pmRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSTrading Update
3rd Dec 20207:00 amRNSUpdate on CMA's Review of Completed Acquisition
2nd Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20204:50 pmRNSHolding(s) in Company
1st Dec 20207:10 amRNSUpdate on CMA's Review of Completed Acquisition
30th Nov 20201:31 pmRNSTotal Voting Rights
24th Nov 20204:55 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSDirectorate Change
18th Nov 20207:00 amRNSTrading Update
9th Nov 20207:00 amRNSAcquisition update
30th Oct 20207:00 amRNSTotal Voting Rights
6th Oct 20207:00 amRNSDirectorate Change
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSTrading Update
10th Sep 20207:13 amRNSCMA's Review of Completed Acquisition
7th Sep 202012:50 pmRNSGrant of SAYE Options and PDMR Dealings
27th Aug 20202:53 pmRNSDirectors' and PDMRs' Dealings
26th Aug 20207:14 amRNSCMA's Review of Proposed Acquisition
19th Aug 20205:30 pmRNSHolding(s) in Company
19th Aug 20205:30 pmRNSHolding(s) in Company
13th Aug 20204:09 pmRNSDirector and PDMR Dealings
3rd Aug 20207:00 amRNSCompletion of acquisition
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSHalf-year Report
8th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 202010:30 amRNSHolding(s) in Company
6th Jul 202010:30 amRNSHolding(s) in Company
19th Jun 20203:41 pmRNSDirector and PDMR Dealings & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.